{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:03:43Z","timestamp":1790507023206,"version":"4.1.0"},"reference-count":298,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014364","name":"National Children's Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02089","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:47:22Z","timestamp":1600429642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Mumps Outbreaks in Vaccinated Populations\u2014Is It Time to Re-assess the Clinical Efficacy of Vaccines?"],"prefix":"10.3389","volume":"11","author":[{"given":"Anna R.","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Ronan","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaythoon","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0065-3527(08)60684-3","article-title":"Mumps virus","volume":"8","author":"Cantell","year":"1961","journal-title":"Adv Virus Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1128\/CDLI.5.6.799-803.1998","article-title":"Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G","volume":"5","author":"Narita","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(52)91357-3","article-title":"Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps)","volume":"2","author":"Simpson","year":"1952","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/adc.62.2.189","article-title":"Hearing loss due to mumps","volume":"62","author":"Hall","year":"1987","journal-title":"Arch Dis Child"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1128\/JCM.00434-10","article-title":"Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland","volume":"48","author":"Carr","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0022-3476(68)80347-6","article-title":"Isolation of virus during the incubation period of mumps infection","volume":"72","author":"Ennis","year":"1968","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/JVI.80.4.1700-1709.2006","article-title":"Function of small hydrophobic proteins of paramyxovirus","volume":"80","author":"Wilson","year":"2006","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/00365540110080043","article-title":"Proposed criteria for classification of new genotypes of mumps virus","volume":"34","author":"Johansson","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijerph15081618","article-title":"Mumps in the vaccination age: global epidemiology and the situation in Germany","volume":"15","author":"Beleni","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S0950268899003659","article-title":"Measles resurgence in Argentina: 1997-8 outbreak","volume":"124","author":"Bilkis","year":"2000","journal-title":"Epidemiol Infect"},{"key":"B12","unstructured":"Immunization: Coverage Data.2020"},{"key":"B13","unstructured":"Triple Viral\/Double Viral.2020"},{"key":"B14","unstructured":"Immunization: Coverage Data of MMR1 and MMR2.2020"},{"key":"B15","unstructured":"National Vaccination Calender.2020"},{"key":"B16","unstructured":"2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1128\/JCM.43.4.1869-1878.2005","article-title":"Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis","volume":"43","author":"Palacios","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/rmv.1819","article-title":"Genomic diversity of mumps virus and global distribution of the 12 genotypes","volume":"25","author":"Jin","year":"2015","journal-title":"Rev Med Virol"},{"key":"B19","unstructured":"Mumps Reported Cases (As of 10 Dec 2019)2019"},{"key":"B20","unstructured":"2.7 Mumps (Last Updated 19 December 2013)2013"},{"key":"B21","unstructured":"CooleyL Mumps Laboratory Case Definitnion; Version 1.02020"},{"key":"B22","unstructured":"Mumps in Austrailia.2020"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1016\/j.vaccine.2019.07.066","article-title":"Parental opinions towards the \u201cNo Jab, No Pay\u201d policy in Australia","volume":"37","author":"Trent","year":"2019","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1473-3099(18)30498-5","article-title":"A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study","volume":"19","author":"Westphal","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e180517","DOI":"10.1590\/0074-02760180517","article-title":"Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study","volume":"114","author":"Santos","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B26","unstructured":"Calend\u00e1rios de Vacina\u00e7\u00e3o SBIm 2019-2020.2020"},{"key":"B27","unstructured":"Informe Tecnico Introducao Vacina Tetraviral 2013. Vacina Sarampo, Caxumba, Rub\u00e9ola e Varicela (Atenuada)2013"},{"key":"B28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am J Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","article-title":"Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain","volume":"20","author":"da Cunha","year":"2002","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jmv.21068","article-title":"Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil","volume":"80","author":"Santos","year":"2008","journal-title":"J Med Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1590\/0037-8682-0320-2016","article-title":"Reemergence of mumps in Sao Paulo, Brazil-the urgent need for booster shot campaign to prevent a serious infectious disease","volume":"50","author":"Urbano","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"B32","unstructured":"Guidelines for the Prevention and Control of Mumps Outbreaks in Canada (Archived). Mumps-Containing Vaccine and Immunization Programs in Canada2009"},{"key":"B33","unstructured":"Guidelines for the Prevention and Control of Mumps Outbreaks in Canada. Mumps-Containing Vaccine and Immunization Programs in Canada"},{"key":"B34","unstructured":"Toronto, ONQueen's Printer for OntarioImmunization Coverage Report for School Pupils in Ontario. 2016\u201317 School Year.2018"},{"key":"B35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.14745\/ccdr.v44i12a01","article-title":"Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017-February 2018","volume":"44","author":"Dubey","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"B36","unstructured":"Guidelines: Mumps in Canada.2010"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1016\/j.vaccine.2018.08.028","article-title":"Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China","volume":"36","author":"Cui","year":"2018","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0169561","DOI":"10.1371\/journal.pone.0169561","article-title":"Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015","volume":"12","author":"Cui","year":"2017","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3201\/eid2404.170591","article-title":"Importation of mumps virus genotype K to China from Vietnam","volume":"24","author":"Liu","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"30156","DOI":"10.2807\/1560-7917.ES.2016.21.10.30156","article-title":"Waning immunity against mumps in vaccinated young adults, France 2013","volume":"21","author":"Vygen","year":"2016","journal-title":"Euro Surveill"},{"key":"B41","unstructured":"Pediatric Vaccines: Global Brands and Country Availability.2018"},{"key":"B42","unstructured":"Mumps2019"},{"key":"B43","volume-title":"Information Sheet Observed Rate of Vaccine Reactions. Measles, Mumps and Rubella Vaccines","year":"2014"},{"key":"B44","unstructured":"2019: Routine Immunization: Regional and Country Profiles; France. Summary of Routine Immunization and Vaccine-Preventable Diseases Surveillance Data, Based Primarily on Data for 2017 Submitted Through the WHO\/UNICEF Joint Reporting Form on Immunization2019"},{"key":"B45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3201\/eid1903.121360","article-title":"Measles elimination efforts and 2008-2011 outbreak, France","volume":"19","author":"Antona","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1086\/368046","article-title":"Progress toward measles elimination in Germany","volume":"187","author":"Hellenbrand","year":"2003","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1016\/j.vaccine.2017.05.084","article-title":"Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China","volume":"35","author":"Zengel","year":"2017","journal-title":"Vaccine"},{"key":"B48","unstructured":"2019: Routine Immunization: Regional and Country Profiles; Germany. Summary of Routine Immunization and Vaccine-Preventable Diseases Surveillance Data, Based Primarily on Data for 2017 Submitted Through the WHO\/UNICEF Joint Reporting Form on Immunization2019"},{"key":"B49","unstructured":"List of the Names, Pharmaceutical Forms, Strengths of the Medicinal Products, Routes of Administration, Marketing Authorisation Holders in the Member States (Annex 1, Article 31)2013"},{"key":"B50","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull World Health Organ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15406\/ijvv.2015.01.00005","article-title":"Live attenuated measles mumps and rubella vaccines: an over view","volume":"1","author":"Naim","year":"2015","journal-title":"Int J Vaccines Vaccin"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1016\/j.vaccine.2008.03.040","article-title":"The epidemiology of mumps in Italy","volume":"26","author":"Gabutti","year":"2008","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","article-title":"Pediatric sentinel surveillance of vaccine-preventable diseases in Italy","volume":"21","author":"Ciofi Degli Atti","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"B54","unstructured":"Vaccine Law2018"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1900371","DOI":"10.2807\/1560-7917.ES.2019.24.26.1900371","article-title":"The law on compulsory vaccination in Italy: an update 2 years after the introduction","volume":"24","author":"D'Ancona","year":"2019","journal-title":"Euro Surveill"},{"key":"B56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(05)75696-8","article-title":"MMR vaccination and autism","volume":"354","author":"Wakefield","year":"1999","journal-title":"Lancet"},{"key":"B57","unstructured":"2020: Annual epidemiological report for 2017; Mumps2020"},{"key":"B58","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1086\/378520","article-title":"Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned","volume":"189","author":"Santos","year":"2004","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00705-016-2770-6","article-title":"Detection of mumps virus genotype H in two previously vaccinated patients from Mexico City","volume":"161","author":"Del Valle","year":"2016","journal-title":"Arch Virol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e0139680","DOI":"10.1371\/journal.pone.0139680","article-title":"Missed opportunities for measles, mumps, and rubella (mmr) immunization in mesoamerica: potential impact on coverage and days at risk","volume":"10","author":"Mokdad","year":"2015","journal-title":"PLoS ONE"},{"key":"B61","unstructured":"El programa nacional de vacunacion: orgullo de Mexico14253 SantosS Rev Fac Med UNAM2002"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1093\/infdis\/jir083","article-title":"Progress toward measles elimination in the Russian Federation, 2003-2009","volume":"204","author":"Onishchenko","year":"2011","journal-title":"J Infect Dis"},{"key":"B63","unstructured":"2019: Routine Immunization: Regional and Country Profiles; Russian Federation. Summary of Routine Immunization and Vaccine-Preventable Diseases Surveillance Data, Based Primarily on Data for 2017 Submitted Through the WHO\/UNICEF Joint Reporting Form on Immunization2019"},{"key":"B64","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1469-0691.2007.01727.x","article-title":"Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004","volume":"13","author":"Atrasheuskaya","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"B65","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/tropej\/48.6.354","article-title":"Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia","volume":"48","author":"Al-Mazrou","year":"2002","journal-title":"J Trop Pediatr"},{"key":"B66","unstructured":"National Immunisation Schedule2019"},{"key":"B67","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5144\/0256-4947.2005.324","article-title":"Measles in Saudi Arabia: from control to elimination","volume":"25","author":"Khalil","year":"2005","journal-title":"Ann Saudi Med"},{"key":"B68","unstructured":"Measles immunization in Saudi Arabia: the need for change82934 KhalilMK Al-MazrouYY Al-JeffriM Al-GhamdyYS East Mediterr Health J72001"},{"key":"B69","unstructured":"Ministries of Health and Education Start a Vaccination Campaign against Measles, Mumps and Rubella.2020"},{"key":"B70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3345\/kjp.2010.53.5.623","article-title":"Reemergence of mumps","volume":"53","author":"Choi","year":"2010","journal-title":"Korean J Pediatr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/jmv.24515","article-title":"Genetic characteristics of mumps viruses isolated in Korea from 2007 to 2012","volume":"88","author":"Kim","year":"2016","journal-title":"J Med Virol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijid.2017.02.011","article-title":"Increasing mumps incidence rates among children and adolescents in the Republic of Korea: age-period-cohort analysis","volume":"57","author":"Choe","year":"2017","journal-title":"Int J Infect Dis"},{"key":"B73","unstructured":"Compulsory Vaccines to be applied to Baby after Birth in Turkey"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/ced.2014.0002","article-title":"The national vaccination schedule in previously healthy children: the practical recommendations about additional vaccines","volume":"8","author":"Arisoy","year":"2014","journal-title":"J Pediatr Infect"},{"key":"B75","unstructured":"2019: Routine Immunization: Regional and Country Profiles; Turkey. Summary of Routine Immunization and Vaccine-Preventable Diseases Surveillance Data, Based Primarily on Data for 2017 Submitted Through the WHO\/UNICEF Joint Reporting Form on Immunization2019"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00705-009-0519-1","article-title":"Genotyping of mumps virus circulating in Turkey in the 2006-2007 winter season","volume":"154","author":"Akcali","year":"2009","journal-title":"Arch Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/aje\/kwk045","article-title":"Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom","volume":"165","author":"Miller","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B78","unstructured":"NHS Vaccinations and When to Have Them"},{"key":"B79","unstructured":"2019: Routine Immunization: Regional and Country Profiles; United Kingdom of Great Britain and Northern Ireland. Summary of Routine Immunization and Vaccine-Preventable Diseases Surveillance Data, Based Primarily on Data for 2017 Submitted Through the WHO\/UNICEF Joint Reporting Form on Immunization2019"},{"key":"B80","unstructured":"Childhood Vaccination Coverage Statistics-England 2018-192019"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.jprot.2011.01.019","article-title":"Proteomics for development of vaccine","volume":"74","author":"Adamczyk-Poplawska","year":"2011","journal-title":"J Proteomics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.oooo.2019.06.012","article-title":"Viral mumps: increasing occurrences in the vaccinated population","volume":"128","author":"Lau","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B83","unstructured":"Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States.2020"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.15585\/mmwr.mm6740a3","article-title":"Vaccination coverage for selected vaccines and exemption rates among children in kindergarten \u2014 United States, 2017\u201318 school year","volume":"67","author":"Mellerson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination coverage among children aged 19\u201335 months \u2014 United States, 2017","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.meegid.2004.02.003","article-title":"The molecular epidemiology of mumps virus","volume":"4","author":"Muhlemann","year":"2004","journal-title":"Infect Genet Evol"},{"key":"B87","volume-title":"The Immunological Basis for Immunization Series Module 16: Mumps","author":"Mclean","year":"2010"},{"key":"B88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/oxfordjournals.aje.a119487","article-title":"Vaccination of human beings against mumps; vaccine administered at the start of an epidemic. I. Incidence and severity of mumps in vaccinated and control groups","volume":"54","author":"Habel","year":"1951","journal-title":"Am J Hyg"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2307\/4585906","article-title":"Preparation of mumps vaccines and immunization of monkeys against experimental mumps infection","volume":"61","author":"Habel","year":"1946","journal-title":"Public Health Rep"},{"key":"B90","unstructured":"Mumps: Vaccine Scheduler"},{"key":"B91","unstructured":"Mumps: Recommended Vaccinations.2018"},{"key":"B92","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"key":"B93","unstructured":"Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype18914 KaaijkP van der ZeijstB BoogM HoitinkC Euro Surveill132008"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1099\/vir.0.013946-0","article-title":"Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2","volume":"90","author":"Chambers","year":"2009","journal-title":"J Gen Virol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1099\/0022-1317-74-5-917","article-title":"The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates","volume":"74","author":"Afzal","year":"1993","journal-title":"J Gen Virol"},{"key":"B96","unstructured":"Definition of an Outbreak"},{"key":"B97","first-page":"100","article-title":"Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)","volume":"46","author":"Chamot","year":"1998","journal-title":"Rev Epidemiol Sante Publique"},{"key":"B98","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jinf.2004.10.001","article-title":"Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population","volume":"51","author":"Ong","year":"2005","journal-title":"J Infect"},{"key":"B99","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1128\/CVI.00621-13","article-title":"Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method","volume":"21","author":"Latner","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.vaccine.2010.02.020","article-title":"Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004","volume":"28","author":"Brockhoff","year":"2010","journal-title":"Vaccine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/INF.0b013e3181d743df","article-title":"Mumps outbreak in the Republic of Moldova, 2007-2008","volume":"29","author":"Schwarz","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"B103","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.2807\/ese.14.50.19440-en","article-title":"Mumps outbreak in Jerusalem affecting mainly male adolescents","volume":"14","author":"Stein-Zamir","year":"2009","journal-title":"Euro Surveill"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2000047","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000047","article-title":"Ongoing mumps outbreak among adolescents and young adults, Ireland, August 2018 to January 2020","volume":"25","author":"Ferenczi","year":"2020","journal-title":"Euro Surveill"},{"key":"B105","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/cid\/cix718","article-title":"Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella vaccination campaign-Iowa, July 2015-May 2016","volume":"66","author":"Shah","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm6729a1","article-title":"Mumps outbreaks at four universities-Indiana, 2016","volume":"67","author":"Golwalkar","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17051686","article-title":"Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine","volume":"17","author":"Su","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00151-19","article-title":"Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity","volume":"33","author":"Lam","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1016\/j.vaccine.2018.06.044","article-title":"A report on the status of vaccination in Europe","volume":"36","author":"Sheikh","year":"2018","journal-title":"Vaccine"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: a historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"key":"B111","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41564-019-0450-5","article-title":"Failure to vaccinate and vaccine failure","volume":"4","year":"2019","journal-title":"Nat Microbiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMp1113569","article-title":"The burden of disease and the changing task of medicine","volume":"366","author":"Jones","year":"2012","journal-title":"N Engl J Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S0025727300048225","article-title":"The politics of prevention: anti-vaccinationism and public health in nineteenth-century England","volume":"32","author":"Porter","year":"1988","journal-title":"Med Hist"},{"key":"B114","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamapediatrics.2013.502","article-title":"A population-based cohort study of undervaccination in 8 managed care organizations across the United States","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr"},{"key":"B115","unstructured":"Meeting of the strategic advisory group of experts on immunization, October 2014-conclusions and recommendations56176Wkly Epidemiol Rec892014"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0181640","DOI":"10.1371\/journal.pone.0181640","article-title":"Misinformation lingers in memory: failure of three pro-vaccination strategies","volume":"12","author":"Pluviano","year":"2017","journal-title":"PLoS ONE"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jamapediatrics.2013.3071","article-title":"Delaying vaccination is not a safer choice","volume":"167","author":"Feemster","year":"2013","journal-title":"JAMA Pediatr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00006454-199901000-00011","article-title":"Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children","volume":"18","author":"Usonis","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"B119","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7326\/M18-2101","article-title":"Measles, mumps, rubella vaccination and autism: a nationwide cohort study","volume":"170","author":"Hviid","year":"2019","journal-title":"Ann Intern Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.vaccine.2013.03.057","article-title":"Measles, mumps and rubella (MMR) vaccination has no effect on cognitive development in children-the results of the Polish prospective cohort study","volume":"31","author":"Mrozek-Budzyn","year":"2013","journal-title":"Vaccine"},{"key":"B121","unstructured":"MMR2019"},{"key":"B122","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/infdis\/169.1.77","article-title":"Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity","volume":"169","author":"Briss","year":"1994","journal-title":"J Infect Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0140-6736(86)92270-1","article-title":"Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland","volume":"1","author":"Peltola","year":"1986","journal-title":"Lancet"},{"key":"B124","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1016\/j.vaccine.2018.05.067","article-title":"Knowledge gaps persist and hinder progress in eliminating mumps","volume":"36","author":"Ramanathan","year":"2018","journal-title":"Vaccine"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"key":"B127","unstructured":"Brief report: update: mumps activity\u2013United States, January 1-October 7, 200611523MMWR Morb Mortal Wkly Rep552006"},{"key":"B128","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2807\/esm.10.09.00559-en","article-title":"An outbreak of mumps in Sweden, February-April 2004","volume":"10","author":"Sartorius","year":"2005","journal-title":"Euro Surveill"},{"key":"B129","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1080\/21645515.2015.1040967","article-title":"Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic","volume":"11","author":"Kaaijk","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B131","first-page":"1","article-title":"Measles prevention","volume":"38","year":"1989","journal-title":"MMWR Suppl"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CVI.00542-16","article-title":"Challenges in interpretation of diagnostic test results in a mumps outbreak in a highly vaccinated population","volume":"24","author":"Trotz-Williams","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ijmm.2015.08.011","article-title":"Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013","volume":"305","author":"Mankertz","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/jmv.21557","article-title":"Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006","volume":"81","author":"Rota","year":"2009","journal-title":"J Med Virol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/CVI.00660-12","article-title":"Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009","volume":"20","author":"Rota","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/CVI.00284-10","article-title":"Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis","volume":"18","author":"Latner","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1016\/j.vaccine.2007.04.013","article-title":"Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements","volume":"25","author":"Park","year":"2007","journal-title":"Vaccine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jcv.2011.12.022","article-title":"Seroepidemiology of the recent mumps virus outbreaks in Ireland","volume":"53","author":"Hassan","year":"2012","journal-title":"J Clin Virol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-018-0996-5","article-title":"Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada","volume":"15","author":"L'Huillier","year":"2018","journal-title":"Virol J"},{"key":"B140","unstructured":"Mumps2019"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20941\/2310-6980.2018.06.1","article-title":"Diagnosis of acute mumps infection during an outbreak in a highly vaccinated population: mumps RNA or mumps IgM detection?","volume":"6","author":"Hassan","year":"2018","journal-title":"Global J Immunol Allergic Dis"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e00405","DOI":"10.1128\/JCM.00405-18","article-title":"Monitoring viral genetic variation as a tool to improve molecular diagnostics for mumps virus","volume":"56","author":"Dilcher","year":"2018","journal-title":"J Clin Microbiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1086\/596207","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"199","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/529141","article-title":"Mumps vaccine performance among university students during a mumps outbreak","volume":"46","author":"Cortese","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B146","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/INF.0000000000001182","article-title":"Emerging mumps infection","volume":"35","author":"Rubin","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"B147","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/INF.0b013e318279f593","article-title":"Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control\u2013Guam 2009 to 2010","volume":"32","author":"Nelson","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"B148","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1542\/peds.56.3.380","article-title":"Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines","volume":"56","author":"Weibel","year":"1975","journal-title":"Pediatrics"},{"key":"B149","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3181\/00379727-165-40967","article-title":"Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines","volume":"165","author":"Weibel","year":"1980","journal-title":"Proc Soc Exp Biol Med"},{"key":"B150","first-page":"39","article-title":"Studies on live attenuated mumps vaccine. I. Comparative field trials with two different live vaccines","volume":"16","author":"Isomura","year":"1973","journal-title":"Biken J"},{"key":"B151","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJM196702022760502","article-title":"Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation","volume":"276","author":"Hilleman","year":"1967","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJM196702022760501","article-title":"Live attenuated mumps-virus vaccine","volume":"276","author":"Weibel","year":"1967","journal-title":"N Engl J Med"},{"key":"B153","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.40.5.798","article-title":"Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic","volume":"40","author":"Young","year":"1967","journal-title":"Pediatrics"},{"key":"B154","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2019.03.013","article-title":"Genomic signature of early T-cell response is associated with lower antibody titer threshold for sterilizing immunity","volume":"166","author":"Ong","year":"2019","journal-title":"Antiviral Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","article-title":"The effectiveness of the mumps component of the MMR vaccine: a case control study","volume":"23","author":"Harling","year":"2005","journal-title":"Vaccine"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","article-title":"Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"B157","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jpids\/piz010","article-title":"Immunogenicity and safety of a measles-mumps-rubella vaccine administered as a first dose to children aged 12 to 15 months: a phase III, randomized, noninferiority, lot-to-lot consistency study","volume":"9","author":"Klein","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B158","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1201-9712(02)90112-8","article-title":"A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children","volume":"6","author":"Lee","year":"2002","journal-title":"Int J Infect Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaccine.2008.10.064","article-title":"Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine","volume":"27","author":"Gillet","year":"2009","journal-title":"Vaccine"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1016\/j.vaccine.2014.04.044","article-title":"Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children","volume":"32","author":"He","year":"2014","journal-title":"Vaccine"},{"key":"B161","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1590\/0074-0276130351","article-title":"Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian national immunisation program","volume":"109","author":"Santos","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.vaccine.2018.01.006","article-title":"Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: a randomized, parallel group, non-inferiority trial","volume":"36","author":"Bavdekar","year":"2018","journal-title":"Vaccine"},{"key":"B163","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jpids\/piu081","article-title":"Safety and immunogenicity of human serum albumin-free MMR vaccine in US children aged 12-15 months","volume":"4","author":"Mufson","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e007202","DOI":"10.1136\/bmjopen-2014-007202","article-title":"Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial","volume":"5","author":"Lalwani","year":"2015","journal-title":"BMJ Open"},{"key":"B165","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00146269","article-title":"Duration of the immune response to MMR vaccine in children of two age-different groups","volume":"9","author":"Li Volti","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","author":"Knuf","year":"2012","journal-title":"Eur J Pediatr"},{"key":"B167","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"key":"B168","unstructured":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)134MMWR Recomm Rep622013"},{"key":"B169","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B170","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1651-2227.1983.tb09660.x","article-title":"Evaluation in young children of the urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain","volume":"72","author":"Vesikari","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"B171","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0264-410X(97)00174-6","article-title":"Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines","volume":"16","author":"Schwarzer","year":"1998","journal-title":"Vaccine"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.vaccine.2005.10.009","article-title":"Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus","volume":"24","author":"Atrasheuskaya","year":"2006","journal-title":"Vaccine"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/infdis\/jir526","article-title":"Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity","volume":"204","author":"Cortese","year":"2011","journal-title":"J Infect Dis"},{"key":"B174","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"key":"B176","first-page":"1","article-title":"Measles, mumps, and rubella\u2013vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"B177","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0264-410X(98)00081-4","article-title":"Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts","volume":"16","author":"Davidkin","year":"1998","journal-title":"Vaccine"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1086\/598482","article-title":"Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination","volume":"199","author":"Vandermeulen","year":"2009","journal-title":"J Infect Dis"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J Infect Dis"},{"key":"B181","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0264-410X(97)88332-6","article-title":"Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme","volume":"16","author":"Broliden","year":"1998","journal-title":"Vaccine"},{"key":"B182","doi-asserted-by":"publisher","first-page":"eaao5945","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.vaccine.2019.02.030","article-title":"Differential durability of immune responses to measles and mumps following MMR vaccination","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"B184","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J Infect Dis"},{"key":"B185","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcv.2015.11.023","article-title":"Mumps outbreaks in a highly vaccinated population: investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus","volume":"74","author":"Kenny","year":"2016","journal-title":"J Clin Virol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/00365540110026593","article-title":"Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 y of age","volume":"33","author":"Gothefors","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"B187","doi-asserted-by":"publisher","first-page":"907.e1","DOI":"10.1016\/j.cmi.2018.11.016","article-title":"Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains","volume":"25","author":"Vermeire","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B188","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N Engl J Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1099\/0022-1317-83-10-2489","article-title":"Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus","volume":"83","author":"Orvell","year":"2002","journal-title":"J Gen Virol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1016\/j.vaccine.2005.10.050","article-title":"Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains","volume":"24","author":"Rubin","year":"2006","journal-title":"Vaccine"},{"key":"B191","doi-asserted-by":"publisher","first-page":"e1004791","DOI":"10.1371\/journal.ppat.1004791","article-title":"Remembering mumps","volume":"11","author":"Latner","year":"2015","journal-title":"PLoS Pathog"},{"key":"B192","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jmv.20064","article-title":"Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000","volume":"73","author":"Utz","year":"2004","journal-title":"J Med Virol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/(sici)1096-9071(199708)52:4<349::aid-jmv1>3.0.co;2-1","article-title":"RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal","volume":"52","author":"Afzal","year":"1997","journal-title":"J Med Virol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1016\/j.vaccine.2016.06.063","article-title":"Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection","volume":"34","author":"Gouma","year":"2016","journal-title":"Vaccine"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1017\/S0950268812001896","article-title":"Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies","volume":"141","author":"Santak","year":"2013","journal-title":"Epidemiol Infect"},{"key":"B196","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1099\/vir.0.000059","article-title":"Identification of conformational neutralization sites on the fusion protein of mumps virus","volume":"96","author":"Santak","year":"2015","journal-title":"J Gen Virol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0971-5916.178587","article-title":"Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes","volume":"143","author":"Vaidya","year":"2016","journal-title":"Indian J Med Res"},{"key":"B198","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: no evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J Virol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/infdis\/jiz480","article-title":"Identification of naturally processed mumps virus epitopes by mass spectrometry: confirmation of multiple CD8+ T-cell responses in mumps patients","volume":"221","author":"de Wit","year":"2020","journal-title":"J Infect Dis"},{"key":"B200","doi-asserted-by":"publisher","first-page":"e58234","DOI":"10.1371\/journal.pone.0058234","article-title":"Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks","volume":"8","author":"Smits","year":"2013","journal-title":"PLoS ONE"},{"key":"B201","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1016\/j.vaccine.2007.04.020","article-title":"Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003","volume":"25","author":"Atrasheuskaya","year":"2007","journal-title":"Vaccine"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1086\/588195","article-title":"Immune responses to mumps vaccine in adults who were vaccinated in childhood","volume":"197","author":"Hanna-Wakim","year":"2008","journal-title":"J Infect Dis"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2249.2005.02931.x","article-title":"Correlations among measles virus-specific antibody, lymphoproliferation and Th1\/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination","volume":"142","author":"Dhiman","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jcpa.2009.10.021","article-title":"Evaluation of the persistence of vaccine-induced protection with human vaccines","volume":"142","author":"Vidor","year":"2010","journal-title":"J Comp Pathol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1017\/S0950268813003427","article-title":"Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study","volume":"142","author":"Borgmann","year":"2014","journal-title":"Epidemiol Infect"},{"key":"B207","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1155\/2009\/493275","article-title":"Laboratory diagnosis of mumps in a partially immunized population: the nova scotia experience","volume":"20","author":"Hatchette","year":"2009","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcv.2014.11.004","article-title":"Mumps outbreak and laboratory diagnosis","volume":"62","author":"Maillet","year":"2015","journal-title":"J Clin Virol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"e8747","DOI":"10.15252\/msb.20188747","article-title":"Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection","volume":"15","author":"Pittala","year":"2019","journal-title":"Mol Syst Biol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.2807\/esw.08.52.02608-en","article-title":"Increase in mumps in Ireland in late 2004","volume":"8","author":"Di Renzi","year":"2004","journal-title":"Euro Surveill"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10096-011-1216-z","article-title":"Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?","volume":"30","author":"Allwinn","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B212","doi-asserted-by":"publisher","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-Muller","year":"2012","journal-title":"PLoS ONE"},{"key":"B213","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/ped.13306","article-title":"Cellular and humoral immunity after vaccination or natural mumps infection","volume":"59","author":"Terada","year":"2017","journal-title":"Pediatr Int"},{"key":"B214","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1016\/j.vaccine.2015.06.113","article-title":"Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers","volume":"33","author":"Terada","year":"2015","journal-title":"Vaccine"},{"key":"B215","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0264-410X(99)00396-5","article-title":"Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination","volume":"18","author":"Bautista-Lopez","year":"2000","journal-title":"Vaccine"},{"key":"B217","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12887-019-1710-5","article-title":"Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s","volume":"19","author":"Geier","year":"2019","journal-title":"BMC Pediatr"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B220","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jmv.1890450104","article-title":"Symptomatic mumps virus reinfections","volume":"45","author":"Gut","year":"1995","journal-title":"J Med Virol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/genomeA.01576-16","article-title":"Complete genome sequence of the WHO international standard for hepatitis B virus DNA","volume":"5","author":"Jenkins","year":"2017","journal-title":"Genome Announc"},{"key":"B222","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/21645515.2017.1413518","article-title":"The establishment of surrogates and correlates of protection: useful tools for the licensure of effective influenza vaccines?","volume":"14","author":"Ward","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B223","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1001\/jama.261.16.2362","article-title":"Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population","volume":"261","author":"Wainwright","year":"1989","journal-title":"JAMA"},{"key":"B224","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/infdis\/jiw142","article-title":"A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen","volume":"214","author":"Simons","year":"2016","journal-title":"J Infect Dis"},{"key":"B225","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/archinte.151.8.1634","article-title":"Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results","volume":"151","author":"Wainwright","year":"1991","journal-title":"Arch Intern Med"},{"key":"B227","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/infdis\/171.1.54","article-title":"Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B","volume":"171","author":"Xu","year":"1995","journal-title":"J Infect Dis"},{"key":"B228","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"19071","DOI":"10.1073\/pnas.1905570116","article-title":"Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood","volume":"116","author":"Rasheed","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0264-410X(00)00392-3","article-title":"Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype","volume":"19","author":"Nojd","year":"2001","journal-title":"Vaccine"},{"key":"B231","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","author":"Gans","year":"2001","journal-title":"J Infect Dis"},{"key":"B232","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2004.12.010","article-title":"Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children","volume":"115","author":"Dhiman","year":"2005","journal-title":"Clin Immunol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2567.2010.03263.x","article-title":"Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice","volume":"131","author":"Vandermeulen","year":"2010","journal-title":"Immunology"},{"key":"B234","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0264-410X(01)00328-0","article-title":"Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes","volume":"20","author":"Nanan","year":"2001","journal-title":"Vaccine"},{"key":"B235","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4161\/hv.27139","article-title":"Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?","volume":"10","author":"Homan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B236","doi-asserted-by":"publisher","first-page":"e01883","DOI":"10.1128\/JVI.01883-18","article-title":"The human CD4(+) T cell response against mumps virus targets a broadly recognized nucleoprotein epitope","volume":"93","author":"de Wit","year":"2019","journal-title":"J Virol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jaci.2017.11.047","article-title":"Mumps infection but not childhood vaccination induces persistent polyfunctional CD8(+) T-cell memory","volume":"141","author":"de Wit","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B238","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1086\/521029","article-title":"Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination","volume":"196","author":"Jokinen","year":"2007","journal-title":"J Infect Dis"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.vaccine.2016.02.070","article-title":"Severity of mumps disease is related to MMR vaccination status and viral shedding","volume":"34","author":"Gouma","year":"2016","journal-title":"Vaccine"},{"key":"B240","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.vaccine.2008.04.075","article-title":"Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students\u2013Iowa, 2006","volume":"26","author":"Marin","year":"2008","journal-title":"Vaccine"},{"key":"B241","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3201\/eid2004.131681","article-title":"Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012","volume":"20","author":"Sane","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"B242","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/21645515.2015.1021522","article-title":"Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases","volume":"11","author":"Zamir","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B243","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1016\/j.vaccine.2011.09.100","article-title":"Transmission of mumps virus from mumps-vaccinated individuals to close contacts","volume":"29","author":"Fanoy","year":"2011","journal-title":"Vaccine"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1086\/587104","article-title":"The duration of mumps virus shedding after the onset of symptoms","volume":"46","author":"Polgreen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1128\/JCM.01803-07","article-title":"Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage","volume":"46","author":"Bitsko","year":"2008","journal-title":"J Clin Microbiol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.15585\/mmwr.mm6647a5","article-title":"Notes from the field: absence of asymptomatic mumps virus shedding among vaccinated college students during a mumps outbreak-Washington, February-June 2017","volume":"66","author":"Bonwitt","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1086\/652770","article-title":"Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change","volume":"50","author":"Kutty","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B248","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurpub\/ckx067","article-title":"Mumps clinical diagnostic uncertainty","volume":"28","author":"Magurano","year":"2018","journal-title":"Eur J Public Health"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1099\/vir.0.062943-0","article-title":"Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012)","volume":"95","author":"Gouma","year":"2014","journal-title":"J Gen Virol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S0950268899004173","article-title":"The European sero-epidemiology network: standardizing the enzyme immunoassay results for measles, mumps and rubella","volume":"125","author":"Andrews","year":"2000","journal-title":"Epidemiol Infect"},{"key":"B251","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-030-00710-2_14","article-title":"Vaccines","volume-title":"Pharmaceutical Biotechnology","author":"Jiskoot","year":"2019"},{"key":"B252","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/risa.12430","article-title":"Systematic review of measles and rubella serology studies","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal"},{"key":"B254","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/21645515.2015.1128600","article-title":"How to determine protective immunity in the post-vaccine era","volume":"12","author":"Charlton","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B255","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int Immunol"},{"key":"B256","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/522432","article-title":"Correlates, surrogates, and vaccines","volume":"196","author":"Sadoff","year":"2007","journal-title":"J Infect Dis"},{"key":"B257","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.biologicals.2012.03.002","article-title":"Aerosolized MMR vaccine: evaluating potential transmission of components to vaccine administrators and contacts of vaccinees","volume":"40","author":"Diaz-Ortega","year":"2012","journal-title":"Biologicals"},{"key":"B258","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B259","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","article-title":"Intranasal immunization with dry powder vaccines","volume":"122","author":"Bahamondez-Canas","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"B260","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"B261","doi-asserted-by":"publisher","first-page":"A40","DOI":"10.1016\/j.vaccine.2011.04.122","article-title":"Live attenuated pandemic influenza vaccine: clinical studies on A\/17\/California\/2009\/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries","volume":"29","author":"Rudenko","year":"2011","journal-title":"Vaccine"},{"key":"B262","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"B263","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/prca.201500054","article-title":"Proteomic contributions to our understanding of vaccine and immune responses","volume":"9","author":"Galassie","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"B264","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/nm.4223","article-title":"Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain","volume":"22","author":"Raymond","year":"2016","journal-title":"Nat Med"},{"key":"B267","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/14760584.2018.1484284","article-title":"Influenza vaccine failure: failure to protect or failure to understand?","volume":"17","author":"Poland","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B268","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/viro.2002.1499","article-title":"Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control","volume":"300","author":"Amexis","year":"2002","journal-title":"Virology"},{"key":"B269","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B270","unstructured":"Outbreak news: mumps virus vaccines4960Wkly Epidemiol Rec72007"},{"key":"B271","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1586\/14760584.2015.1095096","article-title":"Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes","volume":"14","author":"Stobart","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B272","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol Ther"},{"key":"B273","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1128\/JVI.02778-13","article-title":"Immunogenicity of novel mumps vaccine candidates generated by genetic modification","volume":"88","author":"Xu","year":"2014","journal-title":"J Virol"},{"key":"B274","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2015.01.013","article-title":"Discovering protective CD8 T cell epitopes\u2013no single immunologic property predicts it!","volume":"34","author":"Gilchuk","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"B276","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1307","article-title":"Identifying epitopes of HIV-1 that induce protective antibodies","volume":"4","author":"Zolla-Pazner","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtbi.2004.11.006","article-title":"Contrasting B cell- and T cell-based protective vaccines","volume":"234","author":"Jansen","year":"2005","journal-title":"J Theor Biol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol Ther"},{"key":"B279","unstructured":"2020"},{"key":"B280","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1517\/14712598.6.2.135","article-title":"Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications","volume":"6","author":"Pijlman","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes10030189","article-title":"RNA Viruses as tools in gene therapy and vaccine development","volume":"10","author":"Lundstrom","year":"2019","journal-title":"Genes"},{"key":"B282","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coviro.2016.03.003","article-title":"Vaccinology in the third millennium: scientific and social challenges","volume":"17","author":"Poland","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B283","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1208\/s12248-011-9281-x","article-title":"Vaccinomics: current findings, challenges and novel approaches for vaccine development","volume":"13","author":"Ovsyannikova","year":"2011","journal-title":"AAPS J"},{"key":"B284","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B285","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/14760584.2019.1575208","article-title":"The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines","volume":"18","author":"Pezeshki","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"B286","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/hv.7.0.14560","article-title":"Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine","volume":"7","author":"Durando","year":"2011","journal-title":"Hum Vaccin"},{"key":"B287","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3389\/fimmu.2018.02936","article-title":"Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations","volume":"9","author":"Sanchez-Ramon","year":"2018","journal-title":"Front Immunol"},{"key":"B288","doi-asserted-by":"publisher","first-page":"e00907","DOI":"10.1128\/mBio.00907-20","article-title":"Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection?","volume":"11","author":"Fidel","year":"2020","journal-title":"mBio"},{"key":"B289","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biologicals.2005.01.001","article-title":"Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay","volume":"33","author":"Schalk","year":"2005","journal-title":"Biologicals"},{"key":"B290","unstructured":"Evaluation of Medicines for Human Use2006"},{"key":"B291","unstructured":"Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products from Cell Lines of Human or Animal Origin. Step 52008"},{"key":"B292","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1016\/j.vaccine.2018.04.016","article-title":"A framework for research on vaccine effectiveness","volume":"36","author":"Crowcroft","year":"2018","journal-title":"Vaccine"},{"key":"B293","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/174.3.619","article-title":"The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease","volume":"174","author":"Brown","year":"1996","journal-title":"J Infect Dis"},{"key":"B294","first-page":"161","article-title":"Studies on live mumps virus vaccine. V. Development of a new mumps vaccine \u201cAM 9\u201d by plaque cloning","volume":"16","author":"Yamanishi","year":"1973","journal-title":"Biken J"},{"key":"B295","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4161\/mabs.28808","article-title":"Highly parallel characterization of IgG Fc binding interactions","volume":"6","author":"Boesch","year":"2014","journal-title":"MAbs"},{"key":"B296","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.vaccine.2011.12.048","article-title":"The concept of vaccination failure","volume":"30","author":"Heininger","year":"2012","journal-title":"Vaccine"},{"key":"B297","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1542\/peds.2013-2365","article-title":"Effective messages in vaccine promotion: a randomized trial","volume":"133","author":"Nyhan","year":"2014","journal-title":"Pediatrics"},{"key":"B298","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.vaccine.2019.03.003","article-title":"It's not all about autism: the emerging landscape of anti-vaccination sentiment on Facebook","volume":"37","author":"Hoffman","year":"2019","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T03:19:33Z","timestamp":1668827973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":298,"alternative-id":["10.3389\/fimmu.2020.02089"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02089","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"2089"}}